67 related articles for article (PubMed ID: 17251327)
1. Constitutive trafficking--more than just running in circles?
Bohn LM
Mol Pharmacol; 2007 Apr; 71(4):957-8. PubMed ID: 17251327
[TBL] [Abstract][Full Text] [Related]
2. An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor.
McDonald NA; Henstridge CM; Connolly CN; Irving AJ
Mol Pharmacol; 2007 Apr; 71(4):976-84. PubMed ID: 17182888
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors.
Leterrier C; Lainé J; Darmon M; Boudin H; Rossier J; Lenkei Z
J Neurosci; 2006 Mar; 26(12):3141-53. PubMed ID: 16554465
[TBL] [Abstract][Full Text] [Related]
4. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance.
Gómez M; Hernández ML; Pazos MR; Tolón RM; Romero J; Fernández-Ruiz J
Neuroscience; 2008 May; 153(3):687-99. PubMed ID: 18400407
[TBL] [Abstract][Full Text] [Related]
5. Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
Grimsey NL; Goodfellow CE; Scotter EL; Dowie MJ; Glass M; Graham ES
J Neurosci Methods; 2008 Jun; 171(1):78-86. PubMed ID: 18406468
[TBL] [Abstract][Full Text] [Related]
6. mGlu1alpha receptors are co-expressed with CB1 receptors in a subset of interneurons in the CA1 region of organotypic hippocampal slice cultures and adult rat brain.
Boscia F; Ferraguti F; Moroni F; Annunziato L; Pellegrini-Giampietro DE
Neuropharmacology; 2008 Sep; 55(4):428-39. PubMed ID: 18599092
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.
Eggan SM; Lewis DA
Cereb Cortex; 2007 Jan; 17(1):175-91. PubMed ID: 16467563
[TBL] [Abstract][Full Text] [Related]
8. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.
Furuse S; Kawamata T; Yamamoto J; Niiyama Y; Omote K; Watanabe M; Namiki A
Anesthesiology; 2009 Jul; 111(1):173-86. PubMed ID: 19512863
[TBL] [Abstract][Full Text] [Related]
9. Regulation of G protein-coupled receptor trafficking.
Xu ZQ; Zhang X; Scott L
Acta Physiol (Oxf); 2007 May; 190(1):39-45. PubMed ID: 17428231
[TBL] [Abstract][Full Text] [Related]
10. Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface.
Simon AC; Loverdo C; Gaffuri AL; Urbanski M; Ladarre D; Carrel D; Rivals I; Leterrier C; Benichou O; Dournaud P; Szabo B; Voituriez R; Lenkei Z
J Mol Cell Biol; 2013 Aug; 5(4):250-65. PubMed ID: 23585691
[TBL] [Abstract][Full Text] [Related]
11. Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging.
McDonald NA; Henstridge CM; Connolly CN; Irving AJ
Mol Cell Neurosci; 2007 Jun; 35(2):237-48. PubMed ID: 17467290
[TBL] [Abstract][Full Text] [Related]
12. Type I cannabinoid receptor trafficking: all roads lead to lysosome.
Rozenfeld R
Traffic; 2011 Jan; 12(1):12-8. PubMed ID: 21040297
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor homo- and heterodimerization.
Mackie K
Life Sci; 2005 Aug; 77(14):1667-73. PubMed ID: 15978631
[TBL] [Abstract][Full Text] [Related]
14. Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1.
Martini L; Waldhoer M; Pusch M; Kharazia V; Fong J; Lee JH; Freissmuth C; Whistler JL
FASEB J; 2007 Mar; 21(3):802-11. PubMed ID: 17197383
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
16. Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis.
Wolfe BL; Trejo J
Traffic; 2007 May; 8(5):462-70. PubMed ID: 17376169
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons.
Lau T; Schloss P
Eur J Pharmacol; 2008 Jan; 578(2-3):137-41. PubMed ID: 17931621
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid Receptor 1 trafficking and the role of the intracellular pool: implications for therapeutics.
Grimsey NL; Graham ES; Dragunow M; Glass M
Biochem Pharmacol; 2010 Oct; 80(7):1050-62. PubMed ID: 20599795
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
